Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness

  • Authors:
    • Xingwen Wang
    • Changshun Wu
    • Baoying Yuan
    • Dan Wang
    • Huiling Liu
    • Hong Feng
    • Shui Sun
  • View Affiliations

  • Published online on: January 29, 2018     https://doi.org/10.3892/ol.2018.7889
  • Pages: 4604-4610
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Scavenger receptor class B type I (SR‑BI), a well‑documented high‑density lipoprotein receptor, has been implicated in the development and progression of human cancer. However, little is known regarding the expression profile and clinical value of SR‑BI in gastric adenocarcinoma. In the present study immunohistochemistry analysis was performed on a well‑annotated gastric adenocarcinoma tissue microarray to investigate the association between SR‑BI expression and clinicopathological parameters or patient outcome. The results revealed that SR‑BI expression was detected in 69% of the 84 gastric adenocarcinomas. Moreover, a significant association was observed between low SR‑BI expression and poor histological grade, higher Tumor‑Node‑Metastasis T stage, higher N stage and diffuse type carcinoma. Low SR‑BI expression was also significantly associated with a shorter overall survival time in patients with gastric adenocarcinoma, although it was not an independent prognostic factor. Overall, the results of the present study demonstrated that SR‑BI was possibly involved in gastric carcinogenesis and could be used as a biomarker to predict malignancy of gastric adenocarcinoma.

References

1 

McLean MH and El-Omar EM: Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Rahman R, Asombang AW and Ibdah JA: Characteristics of gastric cancer in Asia. World J Gastroenterol. 20:4483–4490. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:518–520. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Guo L, Song Z, Li M, Wu Q, Wang D, Feng H, Bernard P, Daugherty A, Huang B and Li XA: Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. J Biol Chem. 284:19826–19834. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Li Y, Kakinami C, Li Q, Yang B and Li H: Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI. PLoS One. 8:e703902013. View Article : Google Scholar : PubMed/NCBI

6 

Feng H, Guo L, Wang D, Gao H, Hou G, Zheng Z, Ai J, Foreman O, Daugherty A and Li XA: Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol. 31:2543–2551. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Cao WM, Murao K, Imachi H, Yu X, Abe H, Yamauchi A, Niimi M, Miyauchi A, Wong NC and Ishida T: A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res. 64:1515–1521. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP and Frank PG: Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development. Breast Cancer Res. 15:R872013. View Article : Google Scholar : PubMed/NCBI

9 

Wadsack C, Hirschmugl B, Hammer A, Levak-Frank S, Kozarsky KF, Sattler W and Malle E: Scavenger receptor class B, type I on non-malignant and malignant human epithelial cells mediates cholesteryl ester-uptake from high density lipoproteins. Int J Biochem Cell Biol. 35:441–454. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Leon CG, Locke JA, Adomat HH, Etinger SL, Twiddy AL, Neumann RD, Nelson CC, Guns ES and Wasan KM: Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model. Prostate. 70:390–400. 2010.PubMed/NCBI

11 

Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, et al: Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia. 13:309–319. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Zheng Y, Liu Y, Jin H, Pan S, Qian Y, Huang C, Zeng Y, Luo Q, Zeng M and Zhang Z: Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles. Theranostics. 3:477–486. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Lobo MV, Huerta L, Ruiz-Velasco N, Teixeiro E, de la Cueva P, Celdrán A, Martín-Hidalgo A, Vega MA and Bragado R: Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract: Towards the identification of receptors mediating the intestinal absorption of dietary lipids. J Histochem Cytochem. 49:1253–1260. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Berlth F, Bollschweiler E, Drebber U, Hoelscher AH and Moenig S: Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J Gastroenterol. 20:5679–5684. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Yu H and Xin Y: Down-regulated expressions of PPARγ and its coactivator PGC-1 are related to gastric carcinogenesis and Lauren's classification in gastric carcinoma. Chin J Cancer Res. 25:704–714. 2013.PubMed/NCBI

16 

Kwon OK, Kim SW, Chae HD, Ryu SW, Chung HY, Kim SW, Lee WK and Yu W: Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: A retrospective multicenter study. Ann Surg Treat Res. 91:295–302. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Bogan RL and Hennebold JD: The reverse cholesterol transport system as a potential mediator of luteolysis in the primate corpus luteum. Reproduction. 139:163–176. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI

19 

Hu B, El Hajj N, Sittler S, Lammert N, Barnes R and Meloni-Ehrig A: Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 3:251–261. 2012.PubMed/NCBI

20 

Ghandur-Mnaymneh L, Paz J, Roldan E and Cassady J: Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol. 12:96–114. 1988. View Article : Google Scholar : PubMed/NCBI

21 

Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Cancer Genome Atlas Research Network, . Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H and Kelsen DP: Molecular classification of gastric cancer: A new paradigm. Clin Cancer Res. 17:2693–2701. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Shen H, Newmann AS, Hu Z, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wang X and Wei Q: Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: A case-control analysis in China. Oncol Rep. 13:355–360. 2005.PubMed/NCBI

25 

Guo E, Chen L, Xie Q, Chen J, Tang Z and Wu Y: Serum HDL-C as a potential biomarker for nodal stages in gastric cancer. Ann Surg Oncol. 14:2528–2534. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Tamura T, Inagawa S, Hisakura K, Enomoto T and Ohkohchi N: Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients. J Gastroenterol Hepatol. 27:1635–1640. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Caruso MG, Notarnicola M, Cavallini A and Di Leo A: 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer. J Gastroenterol. 37:504–508. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Barresi V, Giuffre G, Vitarelli E, Todaro P and Tuccari G: Caveolin-1 immuno-expression in human gastric cancer: Histopathogenetic hypotheses. Virchows Arch. 453:571–578. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Han J, Parsons M, Zhou X, Nicholson AC, Gotto AM Jr and Hajjar DP: Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation. 110:3472–3479. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Zhao SP, Wu ZH, Hong SC, Ye HJ and Wu J: Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Clin Chim Acta. 365:119–124. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Tsuruoka H, Khovidhunkit W, Brown BE, Fluhr JW, Elias PM and Feingold KR: Scavenger receptor class B type I is expressed in cultured keratinocytes and epidermis. Regulation in response to changes in cholesterol homeostasis and barrier requirements. J Biol Chem. 277:2916–2922. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Kimura T, Mogi C, Tomura H, Kuwabara A, Im DS, Sato K, Kurose H, Murakami M and Okajima F: Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells. J Immunol. 181:7332–7340. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Mardones P, Pilon A, Bouly M, Duran D, Nishimoto T, Arai H, Kozarsky KF, Altayo M, Miquel JF, Luc G, et al: Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem. 278:7884–7890. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Lan D and Silver DL: Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1. J Biol Chem. 280:23390–23396. 2005. View Article : Google Scholar : PubMed/NCBI

35 

Yuan B, Wu C, Wang X, Wang D, Liu H, Guo L, Li XA, Han J and Feng H: High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer. Tumour Biol. 37:3581–3588. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Twiddy AL, Cox ME and Wasan KM: Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells. Prostate. 72:955–965. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Schörghofer D, Kinslechner K, Preitschopf A, Schütz B, Röhrl C, Hengstschläger M, Stangl H and Mikula M: The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. Reprod Biol Endocrinol. 13:882015. View Article : Google Scholar : PubMed/NCBI

38 

Kitadai Y, Sasaki A, Ito M, Tanaka S, Oue N, Yasui W, Aihara M, Imagawa K, Haruma K and Chayama K: Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun. 311:809–814. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, X., Wu, C., Yuan, B., Wang, D., Liu, H., Feng, H., & Sun, S. (2018). Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness. Oncology Letters, 15, 4604-4610. https://doi.org/10.3892/ol.2018.7889
MLA
Wang, X., Wu, C., Yuan, B., Wang, D., Liu, H., Feng, H., Sun, S."Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness". Oncology Letters 15.4 (2018): 4604-4610.
Chicago
Wang, X., Wu, C., Yuan, B., Wang, D., Liu, H., Feng, H., Sun, S."Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness". Oncology Letters 15, no. 4 (2018): 4604-4610. https://doi.org/10.3892/ol.2018.7889